Janux Therapeutics (JANX) Return on Sales (2021 - 2026)
Janux Therapeutics' (JANX) quarterly Return on Sales came in at 0.14% in Q1 2026, up 73.0% year-on-year from 0.08% in Q1 2025, and up 68.55% on a QoQ basis from 0.45% in Q4 2025.
Janux Therapeutics (JANX) Return on Sales (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 6 years of Return on Sales data on file, last reported at 0.14% in Q1 2026.
- On a quarterly basis, Return on Sales rose 73.0% year-over-year to 0.14% in Q1 2026; TTM through Mar 2026 was 0.25%, a 61.0% increase from a year earlier, with the FY2025 full-year figure at 0.14%, up 26.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.14%, up from 0.45% in the prior quarter.
- Over the last five years, Return on Sales for JANX reached as high as 0.05% in Q4 2023 and fell as low as 14.78% in Q2 2025.
- Historically, Return on Sales has averaged 1.73% across 5 years, with a median of 0.3% in 2022.
- On a YoY basis, Return on Sales climbed as much as 765 bps in 2025 and fell as far as 1445 bps in 2025.
- Year by year, Return on Sales stood at 0.06% in 2022, then advanced by 17 bps to 0.05% in 2023, then plunged by 1725 bps to 0.87% in 2024, then soared by 48 bps to 0.45% in 2025, then jumped by 69 bps to 0.14% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 0.14% in Q1 2026, 0.45% in Q4 2025, and 0.13% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Janux Therapeutics | 985.11 Mn | 985.11 Mn | - | -0.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.14% |
| Dec 31, 2025 | -0.45% |
| Sep 30, 2025 | -0.13% |
| Jun 30, 2025 | -14.78% |
| Mar 31, 2025 | -0.87% |
| Dec 31, 2024 | -0.87% |
| Sep 30, 2024 | -7.78% |
| Jun 30, 2024 | -0.33% |
| Mar 31, 2024 | -2.14% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.51% |
| Mar 31, 2023 | -0.27% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -0.30% |
| Jun 30, 2022 | -0.23% |
| Mar 31, 2022 | -0.30% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.72% |
| Jun 30, 2021 | -0.13% |